Rohit Mehta, MD
Cardiovascular Disease · Charlotte, NCNPI 1598989196
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 51.3% of the total. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 521 payments — averaging $361.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$97K
- Philips North America LLC$31K
- Biotronik Inc.$28K
- Biosense Webster, Inc.$14K
- Abbott$11K
- Pfizer$3K
- plus $6K from 16 others
Across 35 payments — averaging $2064.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Impulse Dynamics (USA) Inc.$72K
What the payments were for
- Consulting fees$45,94724%
- Speaking & faculty fees$99,98353%
- Travel & lodging$22,78612%
- Food & beverage$19,77710%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 163 | $96,722 |
| Philips North America LLC | 77 | $30,514 |
| Biotronik Inc. | 76 | $28,216 |
| Biosense Webster, Inc. | 60 | $13,808 |
| Abbott | 50 | $10,612 |
| Pfizer | 3 | $2,765 |
| Atricure, Inc. | 45 | $1,901 |
| Cardiofocus, Inc. | 8 | $1,333 |
| Boston Scientific | 6 | $693 |
| Cvrx, Inc. | 6 | $521 |
| ZOLL Respicardia, Inc. | 1 | $337 |
| Impulse Dynamics (USA) Inc. | 3 | $304 |
| E.r. Squibb & Sons, L.L.C. | 8 | $193 |
| Heartflow, Inc. | 1 | $148 |
| Flowphysix Inc | 1 | $106 |
| Cardiva Medical, Inc. | 1 | $92 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $84 |
| Elutia, Inc. | 1 | $48 |
| GSK | 1 | $38 |
| Johnson & Johnson | 2 | $36 |
| Kestra Medical Technology Services, Inc. | 1 | $27 |
| Altathera Pharmaceuticals LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$17,368
- Carto 3$10,742
- CardioMEMS HF System$6,690
- (5028) IGT Devices Systems Undivided$6,136
- (9124) LM Undivided$3,520
- ELIQUIS$2,751
- AVEIR$2,523
- HeartLight System$1,095
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$823
- EVERA MRI XT DR SURESCAN$809
- CardioSight$725
- IGT Devices Und$603
- IGT D Therapy$500
- Acticor 7 VR-T DX$416
- Selectra$416
- CardioInsight$403
- remede System$337
- Barostim Neo System$304
- WATCHMAN Access System$297
- Micra$283
How this compares
$188,525 in reported general payments places this provider in the 95th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 340 | $391,067 |
| XareltoRivaroxaban | 39 | $52,957 |
| EntrestoSacubitril/Valsartan | 11 | $9,918 |
| Flecainide Acetate | 54 | $2,248 |
| Metoprolol Succinate | 80 | $1,369 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 64 | $1,184 |
| Midodrine Hcl | 16 | $1,085 |
| Diltiazem 24hr ErDiltiazem Hcl | 13 | $595 |
| Potassium Chloride | 18 | $451 |
| Amiodarone Hcl | 42 | $439 |
| Carvedilol | 27 | $427 |
| Furosemide | 49 | $388 |
| Pravastatin Sodium | 12 | $361 |
| Losartan Potassium | 33 | $326 |
| Sucralfate | 28 | $314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $2,765 | $391,067340 claims |
| Johnson & JohnsonXarelto | $36 | $52,95739 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 727 cardiovascular disease providers in North Carolina.
Other cardiovascular disease in Charlotte
- Michael RinaldiCharlotte$722K
- Markus SchererCharlotte$526K
- Sanjeev GulatiCharlotte$406K
- Richard BrowneCharlotte$379K
- Brian PowellCharlotte$160K
- Nicole Cyrille-SupervilleCharlotte$115K
- Noreen KellyCharlotte$84K
- Dermot PhelanCharlotte$76K
- Charles SimontonCharlotte$73K
- Satish MisraCharlotte$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.